NCT07835490Active, not recruiting
Telemonitoring of HFrEF Patients
Telemonitoring of Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
The aim of this study is to find out whether remote health monitoring can help people with chronic heart failure. For 3 months, some patients use a SiDLY CARE PRO electronic wristband. It measures their physical activity, blood oxygen level and heart rate every 15 minutes. The information is sent electronically to a secure database. The study includes two groups of patients. One group uses the wristband and receives regular cardiology care. The other group receives regular care without remote monitoring. During the study, patients have three visits at the cardiology clinic. Their health, heart failure symptoms and treatment are assessed. They also complete short questionnaires about their quality of life and ability to perform everyday activities. The researchers compare the two groups to see whether remote monitoring is associated with better health and fewer hospital stays or deaths related to worsening heart failure. The study began in February 2023 and is planned to continue until 31 December 2028.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 4 Sept 2026
- Start date
- 21 Feb 2023
- Primary completion date
- 4 May 2024
- Lead sponsor
- Medical University of Lodz
- Diseases
- Heart failure
- NCT number
- NCT07835490
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 21 Feb 2023 to the primary completion date, 4 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- myocardial infarction, unstable angina, stroke or transient ischemic attack, coronary revascularization by percutaneous coronary intervention or coronary artery bypass graft, valve replacement surgery or ICD/CRT implantation within 4 weeks prior to study enrollment;
- planned valve replacement surgery;
Other illness
- acute or decompensated heart failure;
- the primary cause of heart failure in the form of active myocarditis, constrictive pericarditis or a valvular heart disease that has not been treated by interventional or surgical means, as defined by the ESC guidelines;
- status after heart transplantation;
- a severe non-cardiovascular disease with a life expectancy of less than 1 year, or a patient condition precluding the performance of the procedures specified in the study protocol;
- diagnosis of malignancy at the time of screening;
- history of an allergic reaction to materials contained in the wristband.
Other
- planned coronary revascularization by percutaneous coronary intervention or coronary artery bypass graft;
- symptomatic bradycardia or third-degree atrioventricular block without a pacemaker;
Who the study is looking for
- provided written informed consent prior to any study specific procedures;
- males and females aged \>18 years old at the time of consent;
- documented diagnosis of HFrEF prior to enrollment and optimally treated with pharmacological and/or device therapy;
- left ventricular ejection fraction ≤40% in a transthoracic echocardiogram from the last 12 months before recruitment;
- NYHA class II-III.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 2nd Department of Cardiology, Medical University of Lodz, Poland Coordinator of this site? Confirm its status | Lodz | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.